Navigation Links
Neurobiological Technologies Announces Suspension of Viprinex Development
Date:1/13/2009

EMERYVILLE, Calif., Jan. 13 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (Nasdaq: NTII) (NTI(R)) today announced that, following a detailed analysis of the recent interim results of the Viprinex(TM) clinical trial, the company has decided not to develop Viprinex further for the treatment of acute ischemic stroke. Viprinex was recently studied in a clinical trial to determine whether it was effective in improving patient outcome when given within six hours of a stroke, but the trial was halted for futility following an interim analysis.

"Following a thorough review of the interim data, it was determined that there was no group of patients in which Viprinex improved outcome, and therefore further development is not warranted," said Warren W. Wasiewski, Chief Medical Officer. "We are very disappointed that another potential treatment for this devastating disease has failed to show benefit for this patient population."

The company also announced that it is reducing its workforce substantially, paring down to the minimum necessary to carry out operations and complete contractual obligations. NTI is terminating a majority of its employees this week, with additional employee terminations planned for February and March. By the end of the first quarter of calendar 2009, the reduction in workforce is expected to aggregate approximately 75% of the staff employed previously. The company is also significantly reducing other operating expenses and plans to provide further disclosure in its Quarterly Report on Form 10-Q for the quarter ended December 31, 2008, which will be filed in February 2009.

"We are disappointed with the results of the Viprinex clinical trials. Following the receipt of these results, we have taken steps to reduce costs to preserve the company's remaining cash and to reduce
'/>"/>

SOURCE Neurobiological Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Neurobiological Technologies, Inc. Reports Receipt of Notice From Nasdaq
2. Neurobiological Technologies, Inc. Reports Fourth Quarter and Fiscal Year-End Financial Results for 2007 Announces 1-for-7 Reverse Stock Split
3. Neurobiological Technologies, Inc. (Nasdaq: NTIID)
4. Neurobiological Technologies Announces Pricing of Its $60 Million Common Stock Offering
5. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q1/08 Review Issued By Scimitar Equity Research, Inc.
6. Neurobiological Technologies, Inc. Reports Retirement of Ronald E. Cape, Ph.D., from Board
7. Neurobiological Technologies Sets Date for Second Quarter Financial Results
8. Update: Neurobiological Technologies Sets Date for Second Quarter Financial Results and Conference Call
9. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q2/08 Review Issued By Scimitar Equity Research, Inc.
10. Neurobiological Technologies Sets Date for Research and Development Day
11. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... (PRWEB) June 02, 2015 ... independent blade-based and rackmount computing and storage infrastructure ... the launch of its high density scale-out, two-in-one ... Cirrascale Slipstream™ RM1622D . The high density, two-in-one ... v4 product family with Intel® Iris™ Pro graphics ...
(Date:6/2/2015)... 2015 “Stem Cell Therapy to help dogs ... it is used often as an adjunct to surgery in ... not yet aware or comfortable enough with the techniques to ... often reserved for the last resort cases - when nothing ... lift a paw to get around. It is an easy ...
(Date:6/2/2015)... LOUIS , June 2, 2015   ... Life Science and Technology company, announced today it ... Science to launch genetically engineered human neural ... advance the research of neurological diseases. These new ... provide unique and versatile tools for the study ...
(Date:6/2/2015)... June 2, 2015  Alere Inc. (NYSE: ... joined the White House Antibiotic Stewardship Forum today ... support and advance the President,s National Action Plan ... a number of measurable goals and objectives over ... help healthcare providers protect their patients through antibiotic ...
Breaking Biology Technology:Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 2Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 3VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities. 2VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities. 3Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells 2Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells 3Alere Announces Broad Initiatives to Help Combat Antibiotic Resistance during White House Antibiotic Stewardship Forum 2
... that could be used in novel security devices to ... sensors, according to research published tomorrow (8 April) in ... which are based on a fundamental science discovery in ... to instantly detect the presence of particular molecules, for ...
... Bulletin Board: TBIO), a leading global biotechnology company, announces ... Dana-Farber Cancer Institute, Boston, MA with regard to a ... standard PCR technology enriches mutations in samples where normal ... Mike Makrigiorgos who has demonstrated its effectiveness in enriching ...
... Calif., April 7 Voler Systems ( http://www.volersystems.com ) ... Program" which provides full-service consulting from concept and design ... economic conditions are not deterring Voler from investing in ... needs and reducing time-to-market for new medical devices. During ...
Cached Biology Technology:New security and medical sensor devices made possible by metallic nanostructures 2Transgenomic Completes Licensing Option With Dana-Farber Cancer Institute on Cold-PCR for Enrichment of DNA Mutations 2Transgenomic Completes Licensing Option With Dana-Farber Cancer Institute on Cold-PCR for Enrichment of DNA Mutations 3Transgenomic Completes Licensing Option With Dana-Farber Cancer Institute on Cold-PCR for Enrichment of DNA Mutations 4Voler Systems Continues Investments and Expands Services 2
(Date:5/14/2015)... 14, 2015 Research and Markets ( ... "Fingerprint Sensors Market in Smart Mobile Devices " ... that 2014 was a watershed year for fingerprint sensors ... ,Apple Pay,. Apple gave fingerprint sensors a raison d,etre ... Fingerprint sensors are a must-have feature in flagship smartphones. ...
(Date:5/11/2015)... a well-rounded UAS delegation representing private industry, government, and academia, ... AUVSI,s Unmanned 2015 conference last week in Atlanta ... UAS industry met with over 200 hundred people from companies ... ecosystem. "Our message is clear and consistent," ... Rich Knoll . "If you want to fly UAS, you ...
(Date:5/8/2015)... , May 8, 2015 Synaptics Inc. (NASDAQ: ... announced that members of the executive management team will present ... Annual Technology, Media and Telecom Conference Date: May 18, ... Boston, MA Cowen and ... Time: 2:45pm ET Location: The New York Palace Hotel, ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Synaptics to Present at Upcoming Investor Conferences 2
... In an effort to reduce the risks of diabetes and ... announced it has partnered with the YMCA of Greater Boston ... Diabetes) Program. The goal of this program is to show ... of cardiovascular disease can be reduced. Funding for the program ...
... Dinosaurs squashed them with impunity. Thousands of species that ... And a study based on advanced DNA analysis has shown ... Finally, however, one animal species came along that would ... reverence homo sapiens. Thus was born the human affection ...
... doctor orders for individuals suffering from dry eye condition, a ... composition. According to a study published in Investigative Ophthalmology ... Celsius on the eye and eyelid could be the cause ... study, (Meibomian Lipid Films and the Impact of Temperature) showed ...
Cached Biology News:Boston Medical Center receives grant from Astrazeneca to 'end diabetes' 2Genetic analysis reveals history, evolution of an ancient delicacy -- morels 2Genetic analysis reveals history, evolution of an ancient delicacy -- morels 3Drop in temperature may explain the increase in dry eye suffering 2
RatTRAPTM Assay is a solid-phase immunofixed enzyme activity assay for the determination of osteoclast-derived TRACP 5b activity in rat serum....
... contains a unique β-agarose digesting enzyme developed ... intact DNA and RNA from low melting ... TAE, TBE, MOPS, or phosphate buffers. The ... TAE, TBE, MOPS, and phosphate electrophoresis buffers ...
... Terminal deoxynucleotidyl transferase (TdT) is an intracellular ... cortical thymocytes and minor subpopulation of bone ... and increased numbers of TdT cells are ... leukaemias and lymphomas. Presence of TdT thus ...
Recombinant Ovine IFN Tau. Active on sheep, cow, human and mouse cells. Activity: 5.7 x 10 7 u/mg...
Biology Products: